Vaccination of patients with advanced non-small cell lung cancer with an optimized cryptic hTERT peptide (Vx-001)

K Kosmatopoulos,E. Bolonaki,A. Kotsakis,Elsa Papadimitraki,D. Agouraki,G. Kosnoslakis,A. Vagia,Charalambos Christophylakis,Vassilis Georgoulias,D. Mavroudis

Vaccination of patients with advanced non-small cell lung cancer with an optimized cryptic hTERT peptide (Vx-001)

2007

K Kosmatopoulos
E. Bolonaki
A. Kotsakis
Elsa Papadimitraki
D. Agouraki
G. Kosnoslakis
A. Vagia
Charalambos Christophylakis
Vassilis Georgoulias
D. Mavroudis

7642 Background: To evaluate the immunological and clinical efficacy of the optimized peptide TERT572Y (Vx-001) presented by HLA-A*0201 in patients with advanced non-small cell lung cancer (NSCLC)....

Keywords:

Telomerase reverse transcriptase
Vaccination
Cell
Lung cancer
Peptide
Biology
Virology
Cancer research
Immunology
in patient
clinical efficacy
non small cell
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations